
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1046 | 940 | 1046 | 902 | 1191 | 1850 |
Fund Return | 4.62% | -5.99% | 4.62% | -3.37% | 3.56% | 6.34% |
Place in category | 518 | 629 | 518 | 427 | 242 | 47 |
% in Category | 78 | 87 | 78 | 77 | 52 | 16 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Pictet CH Institutional Swiss EquZD | 2.25B | 10.28 | 3.87 | 7.82 | ||
Pictet CH Institutional Swiss EquiZ | 2.25B | 8.90 | 2.54 | 8.57 | ||
Pictet CH Institutional Swiss EquiI | 2.25B | 8.86 | 2.05 | 8.05 | ||
Pictet CH Institutional Swiss EquiP | 2.25B | 8.84 | 1.85 | 7.84 | ||
Pictet CH Institutional Swiss EquPD | 2.25B | 4.41 | -3.57 | 6.13 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0033782431 | 2.68B | 12.09 | 5.90 | 7.10 | ||
Pictet CH Institutional Swiss EquZD | 2.25B | 10.28 | 3.87 | 7.82 | ||
Pictet CH Institutional Swiss EquiZ | 2.25B | 8.90 | 2.54 | 8.57 | ||
Pictet CH Institutional Swiss EquiI | 2.25B | 8.86 | 2.05 | 8.05 | ||
Pictet CH Institutional Swiss EquiP | 2.25B | 8.84 | 1.85 | 7.84 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Roche Holding Participation | CH0012032048 | 13.08 | 305.80 | +0.89% | |
Nestle | CH0038863350 | 11.42 | 89.18 | -0.07% | |
Novartis | CH0012005267 | 9.71 | 96.35 | -0.60% | |
ABB | CH0012221716 | 6.06 | 48.90 | +1.49% | |
Richemont | CH0210483332 | 5.50 | 166.75 | +2.18% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Buy | Buy |
Technical Indicators | Strong Sell | Strong Buy | Strong Buy |
Summary | Sell | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review